8-K Alert- Guided Therapeutics Receives $250K Payment from Konica Minolta Optical

Item 8.01. Other Events.

On October 29, 2009, Guided Therapeutics, Inc. ("GT") received a $250,000 payment from Konica Minolta Optical, Inc. (KMOT) as part of a one-year agreement to co-develop non-invasive cancer detection products. On April 30, 2009, GT entered into a one year agreement for $750,000 with KMOT. The Company received $500,000 on the Agreement on May 15, 2009. The co-development agreement follows two years of collaborative preparations to identify large market opportunities that would benefit from GT's proprietary technology. The new products, for the detection of lung and esophageal cancer, are based on the Company's LightTouch^TM non-invasive cervical cancer detection technology, which is undergoing the FDA's premarket approval process. Lung cancer is the most prevalent cancer in the world and esophageal cancer ranks just below cervical cancer in newly diagnosed cases, according to the World Health Organization.